DUBLIN, Feb. 5, 2016 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/ld3fpf/global_sexual) has announced the addition of the "Global Sexual Health Partnering 2010-2016: Deal trends, players and financials" company profile to their offering.
Global Sexual Health Partnering 2010 to 2016 provides the full collection of Sexual Health disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive Sexual Health disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Sexual Health deals.
The report presents financial deal terms values for Sexual Health deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
Global Sexual Health Partnering 2010 to 2016 includes:
In Global Sexual Health Partnering 2010 to 2016, available deals and contracts are listed by:
For more information visit http://www.researchandmarkets.com/research/ld3fpf/global_sexual
Media Contact:
Laura Wood, +353-1-481-1716, [email protected]
SOURCE Research and Markets
Share this article